Citation Impact
Citing Papers
Changes in a Population of Hospitalized Patients with Affective Disorders, 1945-1965
1966
A Meta-Analysis of Cytokines in Major Depression
2009 Standout
Neural Mechanisms of Hierarchical Planning in a Virtual Subway Network
2016 StandoutNobel
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Goals and Habits in the Brain
2013
Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants
2021 Standout
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
2006 Standout
Chlorpromazine versus placebo for schizophrenia
2007
Potential Therapeutic Effects of Psilocybin
2017 Standout
Childhood and Adolescent Depression: A Review of the Past 10 Years. Part I
1996 Standout
Psychiatry & the psychedelic drugs. Past, present & future
2017
Psychedelics
2016 Standout
Reducing Polypharmacy in the Elderly
1990
The Pictet–Spengler Reaction in Nature and in Organic Chemistry
2011 Standout
Dose-Response Study of N,N-Dimethyltryptamine in Humans
1994
Reinforcement Learning, Fast and Slow
2019 StandoutNobel
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
1998 Standout
Incentive‐sensitization and addiction
2001 Standout
Psychosis as a State of Aberrant Salience: A Framework Linking Biology, Phenomenology, and Pharmacology in Schizophrenia
2002 Standout
Smoking and Mental Illness
2000 Standout
Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers
1996
Dopamine receptors and the dopamine hypothesis of schizophrenia
1987
Antipsychotic Properties of the Partial Dopamine Agonist (−)-3-(3-Hydroxyphenyl)-N-n-Propylpiperidine (Preclamol) in Schizophrenia
1998 StandoutNobel
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
1997 Standout
Cigarette smoking and neuroleptic-induced parkinsonism
1990
The neural basis of psychedelic action
2022 Standout
Neuroscience-Inspired Artificial Intelligence
2017 StandoutNobel
Corporal punishment by parents and associated child behaviors and experiences: A meta-analytic and theoretical review.
2002 Standout
Localization of serotonin 5‐HT2 receptors in living human brain by positron emission tomography using N1‐([11C]‐methyl)‐2‐BR‐LSD
1987
Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects
1995
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
The effect of l-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs
1975
Assessing alternative drug control regimes
1996 StandoutNobel
Chlorpromazine versus placebo for schizophrenia
2014
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Benzodiazepines in the Treatment of Epilepsy A Review
1973
Neuroleptic-Induced Decrease in Plasma Homovanillic Acid and Antipsychotic Activity in Schizophrenic Patients
1984 Science
The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series
2010
A Review of REM Sleep Deprivation
1975
Interpersonal Perception: A Social Relations Analysis
1988 Standout
Bromocriptine therapy in chronic schizophrenia: Effects on symptomatology, sleep patterns, and prolactin response to stimulation
1983
Tetrahydroisoquinoline Alkaloids: in vivo Metabolites of L-Dopa in Man
1973 Nature
Neuroleptic-induced parkinsonism in older schizophrenics
1987
Heterogeneity of Psychiatric Diagnosis in Treated Opiate Addicts
1982
Some observations on psilocybin, a new hallucinogen, in volunteer subjects
1960
Antagonism by baclophen of thed-amphetamine-induced disruption of a successive discrimination in the rat
1975 StandoutNobel
Do Authoritarian Attitudes or Authoritarian Personalities Reflect Mental Illness?
1981
Heroin Addict Relationships with Parents during Childhood and Early Adolescent Years
1974
The History of Psychedelics in Psychiatry
2020
Anticonflict effects of low doses of the dopamine agonist apomorphine in the rat
1986 StandoutNobel
Antagonism by haloperidol of the L-DOPA-induced disruption of a successive discrimination in the rat
1975
Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex
1997 Standout
Sex differences in unipolar depression: Evidence and theory.
1987 Standout
Use of antianxiety agents in anxious outpatients
1978
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains
1978 Nature
Drugs, Neurotransmitters, and Schizophrenia
1974 Science
Setting, patient, and doctor effects on drug response in neurotic patients
1970
About Sleep's Role in Memory
2013 Standout
Plasma Levels of Imipramine (IMI) and Desmethylimipramine (DMI) and Clinical Response in Prepubertal Major Depressive Disorder: A Preliminary Report
1979
The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory
1974 Standout
Dopamine in schizophrenia: a review and reconceptualization
1991 Standout
Précis ofThe neuropsychology of anxiety: An enquiry into the functions of the septo-hippocampal system
1982 Standout
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.
1990 Standout
A faulty negative feedback control underlies the schizophrenic syndrome?
1991 StandoutNobel
Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics
1980 Standout
Biogenic Amines and Emotion
1967 Science
Does dopamine play a role in schizophrenia?
1977 StandoutNobel
Sex Differences and the Epidemiology of Depression
1977 Standout
Methylphenidate, Dextroamphetamine, and Levamfetamine
1976
The Neuropsychology of Anxiety
2003 Standout
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
1978 StandoutNobel
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
1976 StandoutScience
The Dopamine Hypothesis of Schizophrenia: A Review*
1976
Authoritarianism and Group Identification: A New View of an Old Construct
1989 Standout
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
1987 Standout
Behavioural despair in rats: A new model sensitive to antidepressant treatments
1978 Standout
Sorting Out the Cuckoo's Nest: A Factorial Survey Approach to the Study of Popular Conceptions of Mental Illness
1988
Changes in Enzymes involved in the Biosynthesis and Metabolism of Noradrenaline and Adrenaline after Psychosocial Stimulation
1970 StandoutNatureNobel
The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
1985 Standout
Reduced Catechol- O -Methyltransferase Activity in Red Blood Cells of Women with Primary Affective Disorder
1970 StandoutScienceNobel
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Industry sponsorship and research outcome
2017 Standout
Hallucinogens
2004 Standout
Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis
1986 Standout
Works of Sidney Merlis being referenced
A CLINICAL TRIAL OF PARGYLINE AND DOPA IN PSYCHOTIC SUBJECTS.
1964
CHLORDIAZEPOXIDE HYDROCHLORIDE (LIBRIUM®) AND JAUNDICE : REPORT OF A CASE
1961
The action of L-dopa on schizophrenic patients (a preliminary report).
1970
Personal Adjustment and Authoritarian Attitudes toward the Mentally ILL
1972
CHEMOTHERAPEUTIC TRIALS IN PSYCHOSIS: III
1958
Action of L-Dopa in drug induced extrapyramidalism.
1970
Polypharmacy in Psychiatry: Patterns of Differential Treatment
1970
CHEMOTHERAPEUTIC TRIALS IN PSYCHOSIS: III. ADDENDUM
1959
Community perception of severity of illness levels of former mental patients: A failure to discriminate
1976
THE EFFECTS OF MESCALINE SULFATE IN CHRONIC SCHIZOPHRENIA
1957
Triiodothyronine and phenothiazines in schizophrenia.
1969
Comparison of emotion profiles as defined by two additional MMPI profile types in male narcotic addicts
1969
THE TREATMENT OF DEPRESSION IN HOSPITALIZED PATIENTS BEFORE AND SINCE THE INTRODUCTION OF ANTIDEPRESSANT DRUGS
1962
Studies on mescaline I. Action in schizophrenic patients
1955
A double-blind comparison of diazepam, chlordiazepoxide and chlorpromazine in psychotic patients.
1962
The use of oxazepam in elderly patients.
1975
A note on some therapeutic implications of the mescaline-induced state
1954
Affective Differential: Comparison of Emotion Profiles Gained from Clinical Judgment and Patient Self-Report
1968
VI. Therapeutic Aspects of the Mescaline-Chlorpromazine Combination
1955
Pharmacokinetics of psychoactive drugs : blood levels and clinical response
1976
Drug-Induced Extrapyramidal Symptoms: Their Incidence and Treatment
1967